United States· US:47783-645_164a1ea0-23e8-405a-a351-80bf513a26eb
TAKHZYRO
A lanadelumab product containing lanadelumab, registered in United States by Takeda Pharmaceuticals America, Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lanadelumab is registered in 15 of 19 countries.
Countries holding a registration under ATC B06AC05 (lanadelumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Lanadelumab · ATC B06AC05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lanadelumab costs, country by country.
Normalised to the WHO defined daily dose (21.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lanadelumab · price per daily dose (21.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$857.11
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LANADELUMAB
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Country
- United States (US)
- ATC code
- B06AC05
- ATC class
- Lanadelumab
- Defined daily dose
- 21.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 20, 2026
Packs & prices · 1
- ndc1147783-645-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lanadelumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTAKHZYROTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- FinlandTakhzyroOrifarm Oy
- BelgiumTakhzyro 150 mgTakeda Pharmaceuticals International Ireland Branch
- United KingdomTakhzyro 150mg/1ml solution for injection pre-filled syringesTakeda UK Ltd
- IcelandTakhzyroTakeda Pharmaceuticals International AG Ireland Branch
- NetherlandsTAKHZYRO 150 mg oplossing voor injectie in voorgevulde spuitTakeda Pharmaceuticals International AG Ireland Branch
- SwedenTAKHZYRO 150 mg Injektionsvätska, lösning i förfylld sprutaTakeda Pharmaceuticals International AG Ireland Branch
- SwitzerlandTAKHZYRO 150 mg, Injektionslösung in einer FertigspritzeTakeda Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Takhzyro
- Liechtenstein · Takhzyro
- Norway · Takhzyro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2b13271-0171-40d8-b0dc-196496f97ca8 GET /v1/drugs/e2b13271-0171-40d8-b0dc-196496f97ca8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "150",
"substance": "LANADELUMAB",
"productndc": "47783-645",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761090",
"marketing_category": "BLA"
}See everything about lanadelumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.